Search results
Jump to navigation
Jump to search
- ...緩和に有効かどうかは明らかではない。また、チアミン欠乏症や集中力低下の治療にも用いられる。強力な[[cholinergic/ja|コリン作動性]][[anxiolytic/ja|抗不安薬]]である。スルブチアミンは人気のある[[nootropic/ja|向精神薬]]であり、使用者は記憶力、集中力の強化、気分や意欲の改善を ...6 KB (295 words) - 11:08, 3 April 2024
- ...iamine deficiency and poor concentration. Being a potent [[cholinergic]] [[anxiolytic]] , Sulbutiamine is a popular [[nootropic]], with users reporting enhanced ...5 KB (702 words) - 11:03, 3 April 2024
- ...iamine deficiency and poor concentration. Being a potent [[cholinergic]] [[anxiolytic]] , Sulbutiamine is a popular [[nootropic]], with users reporting enhanced ...5 KB (738 words) - 11:00, 3 April 2024
- ...できる。オメガ3脂肪酸と[[Omega-6 fatty acid/ja|オメガ6]]脂肪酸は、[[Nociception/ja|抗侵害受容性]]、[[anxiolytic/ja|抗不安性]]、[[Nervous system/ja|神経原性]]の特性を持つ[[Cannabinoid/ja#Endocannabinoids ...43 KB (2,252 words) - 09:46, 27 February 2024
- ...doi=10.1038/bjp.2008.132 |quote = Recent studies also highlight remarkable anxiolytic and prosocial effects of intranasally administered OT in humans, including ...23 KB (3,078 words) - 12:12, 15 November 2023
- CBDは[[5-HT1A receptor/ja|5-HT<sub>1A</sub>受容体]]作動薬であり、[[anxiolytic/ja|抗不安作用]]があるかどうかを調べるための実験研究が行われている。一般に、サティバ種はより刺激的な精神作用のハイをもたらし、インディカ種は身体的 ...76 KB (2,054 words) - 19:53, 7 August 2025
- ...害薬]]（SSRI）を含む）、[[antiemetic/ja|制吐薬]]、[[anticonvulsant/ja|抗けいれん薬]]/抗てんかん薬、[[anxiolytic/ja|抗不安薬]]、[[barbiturate/ja|バルビツール酸薬]]、運動障害（[[Parkinson's disease/ja|パーキンソン病 ...58 KB (1,845 words) - 17:09, 5 November 2023
- ...emetic]]s, [[Anticonvulsant|Anticonvulsant]]s/antiepileptics, [[anxiolytic|anxiolytic]]s, [[barbiturate|barbiturate]]s, movement disorder (e.g., [[Parkinson's di ...52 KB (6,923 words) - 17:09, 5 November 2023
- ...erent groups like: [[stimulant]]s, [[depressant]]s, [[antidepressant]]s, [[anxiolytic]]s, [[antipsychotic]]s, and [[hallucinogen]]s. These psychoactive drugs hav ...31 KB (4,168 words) - 09:37, 7 January 2023
- ...emetic]]s, [[Anticonvulsant|Anticonvulsant]]s/antiepileptics, [[anxiolytic|anxiolytic]]s, [[barbiturate|barbiturate]]s, movement disorder (e.g., [[Parkinson's di ...54 KB (7,245 words) - 17:08, 5 November 2023
- ...ndocannabinoids|endocannabinoids]] with [[Nociception|antinociceptive]], [[anxiolytic]], and [[Nervous system|neurogenic]] properties. ...37 KB (5,301 words) - 12:29, 26 February 2024
- ...ndocannabinoids|endocannabinoids]] with [[Nociception|antinociceptive]], [[anxiolytic]], and [[Nervous system|neurogenic]] properties. ...38 KB (5,433 words) - 12:26, 26 February 2024
- ...s of the American traditional plant Eschscholzia californica: sedative and anxiolytic properties | journal = Planta Medica | volume = 57 | issue = 3 | pages = 21 ...114 KB (14,880 words) - 23:34, 3 January 2023
- ...]] agonist, which is under laboratory research to determine if it has an [[anxiolytic]] effect. It is often claimed that sativa strains provide a more stimulatin ...62 KB (9,106 words) - 14:25, 4 August 2025
- ...]] agonist, which is under laboratory research to determine if it has an [[anxiolytic]] effect. It is often claimed that sativa strains provide a more stimulatin ...64 KB (9,394 words) - 14:24, 4 August 2025